Journal of Urologic Oncology

Editorial

March 31, 2026

Journal of Urologic Oncology at 10 Issues and 100 Articles: Milestones on the Road to a Global Standard

Cheol Kwak

J Urol Oncol. 2026;24(1):1-2.

Guideline

March 31, 2026

Clinical Guideline for the Use of Biodegradable Rectal Spacers During Radiotherapy for Prostate Cancer

Hyun Ho Han, Jong Kyou Kwon, Do Kyung Kim, et al.

J Urol Oncol. 2026;24(1):3-12.

Purpose: Radiotherapy (RT) remains a cornerstone of curative treatment for localized and locally advanced prostate cancer. However, dose escalation to improve tumor control is often constrained by the proximity of...

Original Article

March 31, 2026

Efficacy of Topical Hemostatic Powder on Hemorrhagic Complications After Transrectal Prostate Biopsy: A Randomized Controlled Trial

Jung Hoon Kim, Yong Seong Lee, In Ho Chang, et al.

J Urol Oncol. 2026;24(1):13-20.

Purpose: Topical hemostatic powders may help limit blood loss when applied to a wound early in the course of bleeding. This study evaluated the effectiveness and safety of a hemostatic...

Original Article

March 31, 2026

Risk of Liver and Kidney Adverse Events After Androgen Deprivation Therapy in Prostate Cancer: A Population-Based Retrospective Cohort Study

Jiwoo Yun, Ah-Young Kim, Il-Hyung Hwang, et al.

J Urol Oncol. 2026;24(1):21-33.

Purpose: Androgen deprivation therapy (ADT) is widely used to treat prostate cancer (PC). However, ADT has been associated with various adverse events (AEs) affecting the liver and kidneys. We aimed...

Brief Report

March 31, 2026

Primary Prostatic Mucosa-Associated Lymphoid Tissue Lymphoma: A Comprehensive Review With an Illustrative Case

Sara Duarte, Marco Ferreira, Eduardo Felício, et al.

J Urol Oncol. 2026;24(1):34-40.

Purpose: Prostatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is an exceptionally rare malignancy that often mimics benign prostatic conditions. Its nonspecific symptoms and the frequent absence...

Original Article

March 31, 2026

Disparities in Kidney Cancer Mortality Along the United States-Mexico Border Region: A Retrospective Cohort Analysis From the Centers for Disease Control and Prevention Mortality Data

Manas Pustake, Atharva Railkar, Rajiv Doddamani, et al.

J Urol Oncol. 2026;24(1):41-49.

Purpose: Kidney cancer mortality in the United States exhibits persistent racial, ethnic, and geographic disparities, yet regional patterning of these disparities over time remains incompletely characterized. We conducted a retrospective...

Original Article

March 31, 2026

Radical Nephrectomy and Thrombectomy Without Cardiopulmonary Bypass for Level IV Venous Thrombus Renal Cell Carcinoma: Feasibility and Technical Tips

Dong-Hoon Lim, Hyun Young Lee, Bumjin Lim, et al.

J Urol Oncol. 2026;24(1):50-59.

Purpose: This study evaluated the feasibility of radical nephrectomy and thrombectomy without cardiopulmonary bypass (CPB) in patients with renal cell carcinoma (RCC) and level IV venous tumor thrombus, compared with...

Original Article

March 31, 2026

Initial Experience of Low-Power Holmium Laser En Bloc Resection of Urinary Bladder Tumors in Comparison With TURBT: A Case Series

Shahbaaz Ahmed, Sunirmal Choudhury, Gourab Kundu, et al.

J Urol Oncol. 2026;24(1):60-68.

Purpose: Urinary bladder neoplasms are among the most prevalent urologic cancers. Historically, these tumors have been treated with conventional transurethral resection of bladder tumors (cTURBT), which has widely recognized limitations...

Original Article

March 31, 2026

Postoperative Readmission Is Associated With Worse Oncologic Outcomes After Radical Cystectomy for Bladder Cancer: A Multicenter Study of 3,972 Patients

Jungwon Park, Jong Ho Park, Sangchul Lee, et al.

J Urol Oncol. 2026;24(1):69-78.

Purpose: Radical cystectomy (RC) is associated with substantial postoperative morbidity, and unplanned readmission remains common despite advances in perioperative management. However, the association between postoperative readmission due to complications and...

Original Article

March 31, 2026

Early Morbidity of Retroperitoneal Lymph Node Dissection in Testicular Cancer Patients: A Retrospective Cohort Study of the National Surgical Quality Improvement Program Database

B. Alexander Knight, Andrew Cowan, Solange Bassale, et al.

J Urol Oncol. 2026;24(1):79-87.

Purpose: Complications associated with retroperitoneal lymph node dissection (RPLND) have primarily been described from single-center data. These historical single-center studies often lack standardized reporting preventing combined cohort analysis. Therefore, we...

Review Article

March 31, 2026

DNA Methylation Biomarkers in Genitourinary Cancers: From Analytical Validation to Clinical Translation

Sangmin Lee, In Gab Jeong

J Urol Oncol. 2026;24(1):88-99.

DNA methylation is one of the most extensively characterized epigenetic alterations in cancer and provides a biologically stable, analytically tractable foundation for biomarker development. In genitourinary (GU) oncology, the early...

Current Issue: Volume 24(1); Mar 2026

Journal of Urologic Oncology at 10 Issues and 100 Articles: Milestones on the Road to a Global Standard Cheol Kwak J Urol Oncol. 2026;24(1):1-2. Editorial Mar 31, 2026 Full text PubReader ePub PDF	Clinical Guideline for the Use of Biodegradable Rectal Spacers During Radiotherapy for Prostate Cancer Hyun Ho Han, Jong Kyou Kwon, Do Kyung Kim, et al. J Urol Oncol. 2026;24(1):3-12. Guideline Mar 31, 2026 Prostate Cancer Full text PubReader ePub PDF
Efficacy of Topical Hemostatic Powder on Hemorrhagic Complications After Transrectal Prostate Biopsy: A Randomized Controlled Trial Jung Hoon Kim, Yong Seong Lee, In Ho Chang, et al. J Urol Oncol. 2026;24(1):13-20. Original Article Mar 31, 2026 Prostate Cancer Full text PubReader ePub PDF	Risk of Liver and Kidney Adverse Events After Androgen Deprivation Therapy in Prostate Cancer: A Population-Based Retrospective Cohort Study Jiwoo Yun, Ah-Young Kim, Il-Hyung Hwang, et al. J Urol Oncol. 2026;24(1):21-33. Original Article Mar 31, 2026 Prostate Cancer Full text PubReader ePub PDF Supplementary Material
Primary Prostatic Mucosa-Associated Lymphoid Tissue Lymphoma: A Comprehensive Review With an Illustrative Case Sara Duarte, Marco Ferreira, Eduardo Felício, et al. J Urol Oncol. 2026;24(1):34-40. Brief Report Mar 31, 2026 Prostate Cancer Full text PubReader ePub PDF	Disparities in Kidney Cancer Mortality Along the United States-Mexico Border Region: A Retrospective Cohort Analysis From the Centers for Disease Control and Prevention Mortality Data Manas Pustake, Atharva Railkar, Rajiv Doddamani, et al. J Urol Oncol. 2026;24(1):41-49. Original Article Mar 31, 2026 Kidney Cancer Full text PubReader ePub PDF Supplementary Material
Radical Nephrectomy and Thrombectomy Without Cardiopulmonary Bypass for Level IV Venous Thrombus Renal Cell Carcinoma: Feasibility and Technical Tips Dong-Hoon Lim, Hyun Young Lee, Bumjin Lim, et al. J Urol Oncol. 2026;24(1):50-59. Original Article Mar 31, 2026 Kidney Cancer Full text PubReader ePub PDF	Initial Experience of Low-Power Holmium Laser En Bloc Resection of Urinary Bladder Tumors in Comparison With TURBT: A Case Series Shahbaaz Ahmed, Sunirmal Choudhury, Gourab Kundu, et al. J Urol Oncol. 2026;24(1):60-68. Original Article Mar 31, 2026 Bladder Cancer Full text PubReader ePub PDF
Postoperative Readmission Is Associated With Worse Oncologic Outcomes After Radical Cystectomy for Bladder Cancer: A Multicenter Study of 3,972 Patients Jungwon Park, Jong Ho Park, Sangchul Lee, et al. J Urol Oncol. 2026;24(1):69-78. Original Article Mar 31, 2026 Bladder Cancer Full text PubReader ePub PDF Supplementary Material	Early Morbidity of Retroperitoneal Lymph Node Dissection in Testicular Cancer Patients: A Retrospective Cohort Study of the National Surgical Quality Improvement Program Database B. Alexander Knight, Andrew Cowan, Solange Bassale, et al. J Urol Oncol. 2026;24(1):79-87. Original Article Mar 31, 2026 Bladder Cancer Full text PubReader ePub PDF Supplementary Material
DNA Methylation Biomarkers in Genitourinary Cancers: From Analytical Validation to Clinical Translation Sangmin Lee, In Gab Jeong J Urol Oncol. 2026;24(1):88-99. Review Article Mar 31, 2026 Genitourinary Cancer Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

8,841	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
7,433	Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
7,183	Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
6,361	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
6,359	Determinant of Aggressive Phenotype in Metastatic Hormone-Sensitive Prostate Cancer Depends on an Intrinsic, Highly Aggressive Cell Cluster: Integrated Single-Cell RNA and Whole Transcriptomic Sequencing Analyses

Cited By 10	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 8	Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By 7	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 5	Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
Cited By 4	Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review